IRAK1-independent pathways required for the interleukin-1-stimulated activation of the TpI2 catalytic subunit and its dissociation from ABIN2

Biochemical Journal

Volumn 424, Issue 1, 2009, Pages 109-118

  Handoyo, Hosea ^a   Stafford, Margaret J ^a   McManus, Eamon ^a   Baltzis, Dionissios ^a   Peggie, Mark ^a   Cohen, Philip ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Innate immunity; Interleukin 1 (IL 1); Interleukin 1 receptor associated kinase 1 (IRAK1); Nuclear factor B (NF B); Tumour necrosis factor (TNF); Tumour progression locus 2 (Tpl2)

Indexed keywords

INNATE IMMUNITY; INTERLEUKIN-1 (IL-1); INTERLEUKIN-1-RECEPTOR-ASSOCIATED KINASE 1 (IRAK1); TUMOUR NECROSIS FACTOR (TNF); TUMOUR PROGRESSION LOCUS 2 (TPL2);

AMINO ACIDS; CATALYSIS; CELL CULTURE; DISSOCIATION; GLYCOPROTEINS; MACROPHAGES; PHOSPHORYLATION; POLYSACCHARIDES;

TUMORS;

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 6 CHLORO 8 NICOTINAMIDO BETA CARBOLINE; A20 BINDING INHIBITOR OF IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 2; I KAPPA B; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; PROTEIN KINASE; PROTEIN TYROSINE KINASE; SERINE; THREONINE; TUMOR PROGRESSION LOCUS 2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CATALYSIS; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; NULL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MAP KINASE KINASE KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 70350690506     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20091271     Document Type: Article

References (29)

1. Dumitru, C. D., Ceci, J. D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J. H., Patriotis, C., Jenkins, N. A., Copeland, N. G., Kollias, G. and Tsichlis, P. N. (2000) TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083
2. Kontoyiannis, D., Boulougouris, G., Manoloukos, M., Armaka, M., Apostolaki, M., Pizarro, T., Kotlyarov, A., Forster, I., Flavell, R., Gaestel, M. et al. (2002) Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196, 1563-1574
3. Rousseau, S., Papoutsopoulou, M., Symons, A., Cook, D., Lucocq, J. M., Prescott, A. R., O'Garra, A., Ley, S. C. and Cohen, P. (2008) TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNFα in LPS-stimulated macrophages. J. Cell Sci. 121, 149-154
4. Caivano, M. and Cohen, P. (2000) Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1β in RAW264 macrophages. J. Immunol. 164, 3018-3025
5. Yang, H. T., Cohen, P. and Rousseau, S. (2008) IL-1β-stimulated activation of ERK1/2 and p38α MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-α in HeLa cells. Cell. Signalling 20, 375-380
6. Eliopoulos, A. G., Wang, C. C., Dumitru, C. D. and Tsichlis, P. N. (2003) Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J. 22, 3855-3864
7. Waterfield, M., Jin, W., Reiley, W., Zhang, M. and Sun, S. C. (2004) IκB kinase is an essential component of the Tpl2 signaling pathway. Mol. Cell. Biol. 24, 6040-6048
8. Rodriguez, C., Pozo, M., Nieto, E., Fernandez, M. and Alemany, S. (2006) TRAF6 and Src kinase activity regulates Cot activation by IL-1. Cell. Signalling 18, 1376-1385
9. Hall, J. P., Kurdi, Y., Hsu, S., Cuozzo, J., Liu, J., Telliez, J. B., Seidl, K. J., Winkler, A., Hu, Y., Green, N. et al. (2007) Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood. J. Biol. Chem. 282, 33295-33304
10. Lang, V., Symons, A., Watton, S. J., Janzen, J., Soneji, Y., Beinke, S., Howell, S. and Ley, S. C. (2004) ABIN-2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability. Mol. Cell. Biol. 24, 5235-5248
11. Waterfield, M. R., Zhang, M., Norman, L. P. and Sun, S. C. (2003) NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol. Cell 11, 685-694
12. Aoki, M., Hamada, F., Sugimoto, T., Sumida, S., Akiyama, T. and Toyoshima, K. (1993) The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J. Biol. Chem. 268, 22723-22732
13. Beinke, S., Robinson, M. J., Hugunin, M. and Ley, S. C. (2004) Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Mol. Cell. Biol. 24, 9658-9667
14. Papoutsopoulou, S., Symons, A., Tharmalingham, T., Belich, M. P., Kaiser, F., Kioussis, D., O'Garra, A., Tybulewicz, V. and Ley, S. C. (2006) ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses. Nat. Immunol. 7, 606-615
15. Robinson, M. J., Beinke, S., Kouroumalis, A., Tsichlis, P. N. and Ley, S. C. (2007) Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages. Mol. Cell. Biol. 27, 7355-7364
16. Cho, J., Melnick, M., Solidakis, G. P. and Tsichlis, P. N. (2005) Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an IκB kinase-β-dependent pathway and is required for Tpl2 activation by external signals. J. Biol. Chem. 280, 20442-20448
17. Luciano, B. S., Hsu, S., Channavajhala, P. L., Lin, L. L. and Cuozzo, J. W. (2004) Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity. J. Biol. Chem. 279, 52117-52123
18. Stafford, M. J., Morrice, N. A., Peggie, M. W. and Cohen, P. (2006) Interleukin-1 stimulated activation of the COT catalytic subunit through the phosphorylation of Thr290 and Ser62. FEBS Lett. 580, 4010-4014
19. Miyoshi, J., Higashi, T., Mukai, H., Ohuchi, T. and Kakunaga, T. (1991) Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Mol. Cell. Biol. 11, 4088-4096
20. Jia, Y., Quinn, C. M., Clabbers, A., Talanian, R., Xu, Y., Wishart, N. and Allen, H. (2006) Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization. Anal. Biochem. 350, 268-276
21. Sun, L., Tran, N., Liang, C., Tang, F., Rice, A., Schreck, R., Waltz, K., Shawver, L. K., McMahon, G. and Tang, C. (1999) Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J. Med. Chem. 42, 5120-5130
22. Li, X., Commane, M., Jiang, Z. and Stark, G. R. (2001) IL-1-induced NFκB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc. Natl. Acad. Sci. U.S.A. 98, 4461-4465
23. Alessi, D. R., Cohen, P., Ashworth, A., Cowley, S., Leevers, S. J. and Marshall, C. J. (1995) Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Methods Enzymol. 255, 279-290
24. Gottipati, S., Rao, N. L. and Fung-Leung, W. P. (2008) IRAK1: a critical signaling mediator of innate immunity. Cell. Signalling 20, 269-276
25. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A. and Connelly, P. A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695-701
26. Sakai, R., Iwamatsu, A., Hirano, N., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y. and Hirai, H. (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13, 3748-3756
27. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, J., McLauchlan, H., Klevernic, I., Arthur, S., Alessi, D. and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
28. Yang, J., Cron, P., Good, V. M., Thompson, V., Hemmings, B. A. and Barford, D. (2002) Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat. Struct. Biol. 9, 940-944
29. Conze, D. B., Wu, C. J., Thomas, J. A., Landstrom, A. and Ashwell, J. D. (2008) Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Mol. Cell. Biol. 28, 3538-3547